EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Leeway and I will be your conference operator today.
Source: insidermonkey.com
Page 2 - Jay Duker News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jay Duker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jay Duker Today - Breaking & Trending Today
EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments
– Positive masked safety data update for EYP-1901 in ongoing PAVIA and DAVIO 2 Phase 2 clinical trials as of October 1, 2023 with no drug related ...
Source: businessinsider.com
Seeing is Believing: The Role of Artificial Intelligence in Ophthalmology
Artifical intelligence use is growing across medicine. From imaging to chatbots, ophthalmology is the center of one of these transformations.
Source: hcplive.com
Arbutus Biopharma, EyePoint Pharmaceuticals announce key executive hires
Arbutus Biopharma has promoted Karen Sims to chief medical officer and EyePoint Pharmaceuticals appointed Jay Duker as CEO.
Source: mmm-online.com
Why Are EyePoint Pharmaceuticals Shares Trading Higher Today - EyePoint Pharmaceuticals (NASDAQ:EYPT)
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) shares are trading higher after the company appointed Jay Duker as chief executive officer, transitioning from his most recent role as chief operating
Source: benzinga.com